Affinity DataIC50: 10nMAssay Description:Competitive irreversible inhibition of CDK16/cyclin Y (unknown origin) in presence of Km ATPMore data for this Ligand-Target Pair
Affinity DataIC50: 17.2nMAssay Description:Inhibition of human CDK16/cyclin-Y using RB protein as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
Affinity DataIC50: 24nMAssay Description:Inhibition of human CDK16/cyclin-Y using RB protein as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
Affinity DataIC50: 56nMAssay Description:Inhibition of human CDK16/cyclin-Y using RB protein as substrate incubated for 2 hrs by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
Affinity DataIC50: 135nMAssay Description:Inhibition of human CDK16/cyclin-Y protein-protein complexMore data for this Ligand-Target Pair
Affinity DataIC50: 292nMAssay Description:Inhibition of recombinant GST-tagged inactive state of human CDK16 (108 to end residues)/cyclin Y (2 to end residues)More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 16(Homo sapiens (Human))
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F.
US Patent
Affinity DataIC50: 1.50E+3nMT: 2°CAssay Description:Compound 1 was also assayed to determine the IC50 values for three
different kinases (PCTAIRE1, DYRK1a, and CDK2) in comparison to Gsk3beta. The ass...More data for this Ligand-Target Pair
Affinity DataIC50: 3.83E+3nMAssay Description:Inhibition of kinase tracer 236 binding to recombinant human N-terminal GST-tagged human CDK16 (107 to end residues)/Cyclin Y (2 to end residues) exp...More data for this Ligand-Target Pair